Amygdalin may help prevent some cancers
By Jimmy Downs
Thursday May 16, 2013 (foodconsumer.org) -- Amygdalin (laetrile or vitamin B17) and other glycosides isolated from Prunus Persica seeds may help prevent some cancers, according to a study led by T. Fukuda and colleagues from Okayama University in Kyoto, Japan
The study published in the Biol Pharm Bull. found that four minor ingredients, namely beta-gentiobioside and beta-D-glucoside and beta-gentiobioside and beta-D-glucoside and the major cyanogenic glycosides, namely amygdalin and prunasin have strong anti-tumor promoting activity in vitro and in vivo.
Specifically, "All of the compounds significantly inhibited the Epstein-Barr virus early antigen activation induced by tumor promoter. In addition, they produced a delay of two-stage carcinogenesis on mouse skin that was comparable in potency to (-)-epigallocatechin gallate from green tea," reported the researchers.
Epstein-Barr virus is known to cause some types of cancers if not all cancers.
Amygdalin along with other nutritional therapies effectively cure a variety of advanced cancers in patients who could no longer be helped by conventional cancer treatments, according to a book titled Alive and Well authored by late physician Philip E. Binzel who effectively treated hundreds of patients with advanced cancers using this treatment.
G. Edward Griffin reports in his book titled "World Without Cancer" that amygdalin or vitamin B17 is an important anti-cancer drug that has been rejected by the medical circle.
Amygdalin is found in thousands of plants. Apricot kernels and apple seeds are two common sources of this anti tumor compounds. Apricot kernels have been used as a Chinese medicine in China for thousands of years.
(Send your news to firstname.lastname@example.org, Foodconsumer.org is part of the Infoplus.com ™ news and information network)
- Book News: Wellness Activist Melanie Young Announces "Fearless Fabulous You!" - New Book and Radio Show
- Psoriasis Treatments Are Getting More Personalized
- Defendants Settle FTC Charges Related to “Your Baby Can Read” Program
- Just. Plain. Wrong. - Newsletter from Organic Consumers Association
- NIH to launch human safety study of ebola vaccine candidate